Discuss This Drug

Atracurium

CHEBI:CHEBI_2914

Definition

A diester compound consisting of pentane-1,5-diol with both hydroxyls bearing 3-[1-(3,4-dimethoxybenzyl)-6,7-dimethoxy-2-methyl-3,4-dihydroisoquinolinium-2(1H)-yl]propanoyl groups.

Chemical Information

Molecular Formula
C53H72N2O12
Molecular Mass
929.14500
Charge
+2
SMILES
COc1ccc(CC2c3cc(OC)c(OC)cc3CC[N+]2(C)CCC(=O)OCCCCCOC(=O)CC[N+]2(C)CCc3cc(OC)c(OC)cc3C2Cc2ccc(OC)c(OC)c2)cc1OC
InChI
InChI=1S/C53H72N2O12/c1-54(22-18-38-32-48(62-7)50(64-9)34-40(38)42(54)28-36-14-16-44(58-3)46(30-36)60-5)24-20-52(56)66-26-12-11-13-27-67-53(57)21-25-55(2)23-19-39-33-49(63-8)51(65-10)35-41(39)43(55)29-37-15-17-45(59-4)47(31-37)61-6/h14-17,30-35,42-43H,11-13,18-29H2,1-10H3/q+2
InChIKey
YXSLJKQTIDHPOT-UHFFFAOYSA-N

Alternative Names

  • 2,2'-{pentane-1,5-diylbis[oxy(3-oxopropane-3,1-diyl)]}bis[1-(3,4-dimethoxybenzyl)-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinolinium]
  • Atracurium
  • ATRACURIUM
  • 1-[(3,4-dimethoxyphenyl)methyl]-2-[3-({5-[(3-{1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-2-ium-2-yl}propanoyl)oxy]pentyl}oxy)-3-oxopropyl]-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-2-ium

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

core#notation
CHEBI:2914
oboInOwl#hasDbXref
Wikipedia:Atracurium
DRON_00010000
1218

Additional References

Wikipedia:Atracurium

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

core#notation
CHEBI:2914
active_ingredient_strength
100 mg/10mL
pharm_class
Nondepolarizing Neuromuscular Blocker [EPC]
active_ingredient_name
ATRACURIUM BESYLATE
unii
40AX66P76P
spl_set_id
f7b6a720-05a7-4d6a-9200-21bdc90fc1c4
upc
0355150217106
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class
oboInOwl#hasOBONamespace
chebi_ontology
oboInOwl#hasDbXref
Wikipedia:Atracurium
DRON_00010000
1218
oboInOwl#id
CHEBI:2914
oboInOwl#hasAlternativeId
CHEBI:406485
rxcui
1718913
product_type
BULK INGREDIENT
listing_expiration_date
20241231
marketing_category
BULK INGREDIENT
dosage_form
INJECTION, SOLUTION
route
INTRAVENOUS
labeler_name
Hospira, Inc.
manufacturer_name
Hospira, Inc.
marketing_start_date
20130529
package_marketing_start_date
20130529
generic_name
ATRACURIUM BESYLATE
brand_name
Atracurium Besylate
brand_name_base
Atracurium Besylate
product_ndc
0409-1105
spl_id
12db80ae-2d05-4941-8c95-8ff454a31d80
package_ndc
0409-1105-02
package_description
10 VIAL, MULTI-DOSE in 1 CARTON (0409-1105-02) / 10 mL in 1 VIAL, MULTI-DOSE (0409-1105-22)
application_number
ANDA090761
RO_0000087
http://purl.obolibrary.org/obo/CHEBI_48878
oboInOwl#inSubset
http://purl.obolibrary.org/obo/chebi#3_STAR
has_treatment
http://purl.obolibrary.org/obo/DOID_0070012
rdf-schema#domain
https://w3id.org/def/predibionto#has_side_effect14969
owl#annotatedSource
t169858
owl#someValuesFrom
t2994960